Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model.

Front Immunol · 2023 · PMC10801642 · PMID 38259435

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

approaching significancep ≤ 0.12not close (p > 0.1)

PD-L1mAb also increased ACE on lung monocytes, eosinophils, neutrophils, and CD19 cells at day 5 in trends approaching significance ( p ≤ 0.12).

also in 1,619 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.